Laser Rejuvenation Clinics Edmonton D.T. Inc.
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mosaddiq, Shahira
EMBARQ-CSU2, NCT06455202: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mosaddiq, Shahira
EMBARQ-CSU2, NCT06455202: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

Recruiting
3
915
Europe, Canada, US, RoW
barzolvolimab, Matching placebo
Celldex Therapeutics
Chronic Spontaneous Urticaria
10/26
04/27

Download Options